TOP 100 WEIGHT LOSS SITES
| |||
|
| |||
| |||
|
| |||
| Genes Affect Weight Loss Drug Effectiveness A study conducted by researchers at Mayo Clinic shows that obese patients with specific genetic makeup had enhanced response to the weight loss drug sibutramine, while others who lack these genetic factors lost little or no weight. The findings are published in the October issue of Gastroenterology (http://www.gastrojournal.org). medicalnewstoday.com |
Steady Rates Of Obesity Not Good Enough - Australian Medical Association Today's news that the rate of childhood obesity in Australia has not increased in the last decade must not detract from the urgent need to reduce childhood obesity. Research results released today by the University of South Australia found that obesity rates among children levelled off in the late 1990s and have remained steady since. AMA President, Dr Rosanna Capolingua, said this was good news but not the answer to the overall problem. medicalnewstoday.com |
Large Study Documents How P53 Mutations Link To High-Grade Breast Cancer, Poor Outcomes In what is believed to be the largest study of its kind in the US, researchers have found that almost 26 percent of women studied who have breast cancer have mutations in a gene important in controlling cell growth and death, and that patients with mutations in this gene - known as p53 - had poorer outcomes including a significantly increased risk of death from the cancer. medicalnewstoday.com |
Active Video Games A Good Alternative For Kids Scientists at the University of Oklahoma Health Sciences Center have found that playing active video games can be as effective for children as moderate exercise. The findings appear this week in the journal Pediatrics from the American Academy of Pediatrics. medicalnewstoday.com |
GI Dynamics' EndoBarrier™ Gastrointestinal Liner Demonstrates Safety And Efficacy In Pre-surgical Weight Loss GI Dynamics, a leader in non-surgical treatments for type 2 diabetes and obesity, announced data which support the safety and efficacy of the EndoBarrier™ Gastrointestinal Liner for pre-surgical weight loss treatment, along with a positive effect on glucose homeostasis in morbidly obese patients with type 2 diabetes mellitus. According to the study, mean excess weight loss (EWL) achieved after 12 weeks post implantation was 19.0 % for EndoBarrier patients versus 6. medicalnewstoday.com |